Vinva Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$17.2M |
| 2 |
Apple
AAPL
|
+$14.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 4 |
Microsoft
MSFT
|
+$10.9M |
| 5 |
NVIDIA
NVDA
|
+$7.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$4.19M |
| 2 |
Lennar Class A
LEN
|
+$3.95M |
| 3 |
Reliance Steel & Aluminium
RS
|
+$3.95M |
| 4 |
Royal Caribbean
RCL
|
+$3.69M |
| 5 |
Steel Dynamics
STLD
|
+$3.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.76% |
| 2 | Financials | 14.39% |
| 3 | Healthcare | 12.74% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Communication Services | 7.21% |
Similar funds
Vinva Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Vinva Investment Management held 417 positions worth $1.47B, up 37% from $1.07B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Vinva Investment Management deployed $247M of net new capital in Q4 2023, opening 62 new positions and adding to 255 existing holdings. Its largest new stake was UnitedHealth: 32,283 shares worth $16.9M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Idexx Laboratories, an estimated $4.19M trimmed.
- Vinva Investment Management's largest Q4 2023 buy was UnitedHealth: 32,283 shares worth $16.9M.
- Vinva Investment Management added most to Apple in Q4 2023, an estimated $14.3M increase.
- Vinva Investment Management's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.19M.
- Vinva Investment Management fully exited Clorox in Q4 2023, selling an estimated $3.43M.
- Vinva Investment Management's ten largest holdings make up 29% of its $1.47B portfolio in Q4 2023.
- Vinva Investment Management opened 62 new positions and closed 27 in Q4 2023.
- Vinva Investment Management's portfolio value rose 37% quarter-over-quarter to $1.47B.
Based on Vinva Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.